Clinical Pharmacy

CP-088

DO PATIENTS RECEIVE MEDICATIONS ADJUSTED TO THEIR INDIVIDUAL REQUIREMENTS?

CP-086

CD69 A>G (RS11052877) GENETIC POLYMORPHISM ON THE RESPONSE OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS.

CP-081

INNOVATION AND DEVELOPMENT IMPACT OF ACTIVITIES IN ANTIMICROBIAL STEWARDSHIP PROGRAMMES (ASP)

CP-079

FACTOR IX INHIBITOR DEVELOPMENT IN CONGENITAL HAEMOPHILIA B PATIENTS WITH NONACOG ALFA TREATMENT

CP-076

SAFETY PROFILE OF GLATIRAMER ACETATE 40mg

CP-072

CURRENT VENOUS THROMBOEMBOLISM PROPHYLAXIS PERI-CORONARY ARTERY BYPASS GRAFTING AT ST. THOMAS’ HOSPITAL

CP-069

COMPARISON OF THE DURATION OF EFFECT OF TWO HYALURONIC ACIDS IN KNEE OSTEOARTHRITIS

CP-064

EFFECTIVENESS OF NEW DIRECT ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C DEPENDING ON GENOTYPE IN REAL MEDICAL PRACTICE

CP-063

ASSESSMENT OF URINARY 8-HYROXYDEOXYGUANOSINE LEVEL IN DIABETIC CANCER PATIENTS

CP-062

INFLIXIMAB IN REFRACTORY COELIAC DISEASE

CP-058

ANALYSIS OF CHANGES IN MANAGEMENT OF CATHETER RELATED INFECTIONS IN HAEMODIALYSIS AFTER IMPLEMENTATION OF A PROTOCOL

CP-057

OPTIMIZING PHARMACOTHERAPY IN INSTITUTIONALISED ELDERLY PATIENTS: THE ROLE OF HOSPITAL PHARMACISTS

CP-052

ECONOMIC ASPECTS OF THE USE OF CARBAPENEMS IN CRITICALLY ILL PATIENTS

CP-047

EVALUATION OF THE CLINICAL PHARMACISTS IMPACT ON TOTAL PARENTERAL NUTRITION PRESCRIPTION ORDER REVIEW AND PREPARATION IN NEONATAL INTENSIVE CARE UNIT

CP-046

AN ASSESSMENT OF PREFERENCE OF VISUAL AND MANUAL COMPLIANCE AIDS

Pages